Showing results (1111-1120 of 1,298) with videos related to

Sort By:
Pageof 130
Neurotoxicology|May 23, 2026
A Critical Review of Potential Modifiers of Air Pollutant Associations with Dementia and Related OutcomesJeongWon Han, Yina Li, Sangji Lee, et al.
Pediatrics|May 20, 2009
Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosisJohn T Kanegaye, Lise E Nigrovic, Richard Malley, et al.
International Journal of MS Care|December 22, 2016
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific CircumstancesScott D Newsome, Philip J Aliotta, Jacquelyn Bainbridge, et al.
International Journal of MS Care|March 1, 2017
A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and BeyondScott D Newsome, Philip J Aliotta, Jacquelyn Bainbridge, et al.
The Journal of Urology|April 12, 2005
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic ratsNelson E Bennett, Jang H Kim, Darren P Wolfe, et al.
Scientific Reports|November 28, 2024
Differential regulation of brain microvessel transcriptome and brain metabolome by western and heart-healthy dietary patterns in Ossabaw pigsGloria Solano-Aguilar, Gregory Matuszek, Nirupa R Matthan, et al.
The Journal of Pediatrics|July 15, 2021
Electrocardiogram as a Lyme Disease Screening TestDesiree N Neville, Mark E Alexander, Jonathan E Bennett, et al.
Frontiers in Nutrition|March 27, 2023
Demonstrating a link between diet, gut microbiota and brain: <sup>14</sup>C radioactivity identified in the brain following gut microbial fermentation of <sup>14</sup>C-radiolabeled tyrosine in a pig modelMargaret Murray, Christopher K Barlow, Scott Blundell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Population-based monitoring of HIV drug resistance in Namibia with early warning indicatorsSteven Y Hong, Anna Jonas, Efraim Dumeni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Pageof 130